In The News

Alcon opens eye-drug plant here

EYE-care firm Alcon yesterday officially opened its first Asia-Pacific eye-care drug manufacturing plant here, a facility housing production, packaging and distribution under one roof. The $200 million plant, which started commercial operations last July, spans 330,000 sq ft of space in Tuas Biomedical Park. It is equipped with high-speed aseptic filling capabilities to produce 25 million bottles...


Novartis unit opens $200m plant in Tuas

A PLANT that officially opened yesterday will allow large numbers of eye-related drugs to be produced from a single complex. The $200 million manufacturing facility at Tuas Biomedical Park II was built by Alcon, the eyecare arm of Swiss pharmaceutical giant Novartis. It uses an innovative system with a "single, seamless process" that can produce about 24 million units of drugs a year. Other firms...


New plant in Tuas to produce diabetic drug

DRUG giant Merck Sharp & Dohme will officially open a facility specialising in making the diabetic medication Janumet in Tuas later this year. The plant is part of a US$250million (S$316million) agreement with the Singapore Economic Development Board made in 2011. It calls for Merck Sharp & Dohme to expand manufacturing facilities over 10 years in addition to increasing biotech operations and...


More news...

Events |

More
More events...